AIIMS Delhi, IIT Bhubaneswar launch initiative to revolutionise medical training

Written By :  Kajal Rajput
Published On 2026-01-10 06:45 GMT   |   Update On 2026-01-10 06:45 GMT
Advertisement

Bhubaneswar: The premier health institution, the All India Institute of Medical Sciences (AIIMS) Delhi, has launched a health-education initiative in collaboration with the IIT Bhubaneswar Research and Entrepreneurship Park (IIT Bhubaneswar REP) to promote mental health care and enhance medical training across the country. 

IIT Bhubaneswar sources said under a newly signed Memorandum of Understanding (MoU), the two institutions will jointly implement two pioneering projects aimed at strengthening the skills and well-being of healthcare professionals.

Advertisement

The first initiative, AASHA–HOPE (Manasa Santulan), will focus on training postgraduate doctors in mental health through advanced, AI-driven habit-building tools. These tools are designed to enhance both clinical practice and self-care among medical professionals, news agency UNI reported.

Also Read:AIIMS Delhi introduces free drug monitoring tests for epilepsy patients

The second project, Everyday Hero – Gamification of Training for Healthcare Workers, will use gamification techniques to make medical training more engaging, practical, and outcome-oriented. 

Both projects will be implemented with the support of domain experts from IIT Bhubaneswar REP, in collaboration with Thinkspace Edutech.

These initiatives are expected to benefit all AIIMS campuses and over 75,000 postgraduate doctors across the country, marking a significant step toward strengthening India’s healthcare workforce and fostering innovation in medical education. 

Medical Dialogues had earlier reported that the All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy from January 1, significantly reducing the need for testing at private laboratories, the institute said. Epilepsy is a chronic brain disorder causing recurrent seizures, which are sudden bursts of abnormal electrical activity, leading to symptoms like muscle jerking, confusion, loss of awareness, or psychological changes.  

In a statement, AIIMS explained that the drug monitoring test will measure the concentration of specific medications in a patient’s blood. This will ensure the dosage is both safe and effective.  

Also Read:AIIMS Bhubaneswar opens Neuromodulation Centre for Psychiatric Disorders

Tags:    
Article Source : UNI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News